Proton MR spectroscopic imaging of basal ganglia and thalamus in neurofibromatosis type 1: Correlation with T2 hyperintensities

Neuroradiology

Volumn 53, Issue 2, 2011, Pages 141-148

  Barbier, Charlotte ^a   Chabernaud, Camille ^a   Barantin, Laurent ^a   Bertrand, Philippe ^a   Sembely, Catherine ^a   Sirinelli, Dominique ^a   Castelnau, Pierre ^a   Cottier, Jean Philippe ^a  

^a UNIVERSITÉ DE TOURS   (France)

Author keywords

Basal ganglia; MRI; Neurofibromatosis; Spectroscopy; Thalamus

Indexed keywords

ADOLESCENT; ARTICLE; BASAL GANGLION; BRAIN DAMAGE; BRAIN STEM; CAUDATE NUCLEUS; CEREBELLUM; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; HUMAN; IMAGE ANALYSIS; MALE; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PUTAMEN; SCHOOL CHILD; THALAMUS; WHITE MATTER;

ADOLESCENT; BASAL GANGLIA; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NEUROFIBROMATOSIS 1; PROTONS; STATISTICS AS TOPIC; THALAMUS;

EID: 79953815846     PISSN: 00283940     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00234-010-0776-4     Document Type: Article

References (35)

1. Pont MS, Elster AD (1992) Lesions of skin and brain: modern imaging of the neurocutaneous syndromes. AJR Am J Roentgenol 158:1193-1203
2. Caldemeyer KS, Mirowski GW (2001) Neurofibromatosis type 1. Part I. Clinical and central nervous system manifestations. J Am Acad Dermatol 44:1025-1026 (Pubitemid 32493455)
3. Metheny LJ, Cappione AJ, Skuse GR (1995) Genetic and epigenetic mechanisms in the pathogenesis of neurofibromatosis type I. J Neuropathol Exp Neurol 54:753-760
4. Shen MH, Harper PS, Upadhyaya M (1996) Molecular genetics of neurofibromatosis type 1. J Med Genet 33:2-17
5. Norfray JF, Darling C, Byrd S, Ross BD, Schwalm C, Miller R, Tomita T (1999) Short TE proton MRS and neurofibromatosis type 1 intracranial lesions. J Comput Assist Tomogr 23:994-1003
6. Menor F, Marti-Bonmati L, Arana E, Poyatos C, Cortina H (1998) Neurofibromatosis type 1 in children: MR imaging and follow-up studies of central nervous system findings. Eur J Radiol 26:121-131 (Pubitemid 28078978)
7. Herron J, Darrah R, Quaghebeur G (2000) Intra-cranial manifestations of the neurocutaneous syndromes. Clin Radiol 55:82-98 (Pubitemid 32054530)
8. Payne JM, Moharir MD, Webster R, North KN (2010) Brain structure and function in neurofibromatosis type 1: current concepts and future directions. J Neurol Neurosurg Psychiatry 81:304-309
9. Bennett MR, Rizvi TA, Karyala S, McKinnon RD, Ratner N (2003) Aberrant growth and differentiation of oligodendrocyte progenitors in neurofibromatosis type 1 mutants. J Neurosci 23:7207-1732
10. DiPaolo DP, Zimmerman RA, Rorke LB, Zackai EH, Bilaniuk LT, Yachnis AT (1995) Neurofibromatosis type 1: pathologic substrate of high-signal-intensity foci in the brain. Radiology 195:721-724
11. Daginakatte GC, Gianino SM, Zhao NW, Parsadanian AS, Gutmann DH (2008) Increased c-Jun-NH2-kinase signaling in neurofibromatosis-1 heterozygous microglia drives microglia activation and promotes optic glioma proliferation. Cancer Res 68:10358-10366
12. Williams VC, Lucas J, Babcock MA, Gutmann DH, Korf B, Maria BL (2009) Neurofibromatosis type 1 revisited. Pediatrics 123:124-133
13. Moore BD, Slopis JM, SChomer D, Jackson EF, Levy BM (1996) Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis. Neurology 46:1660-1668 (Pubitemid 26185789)
14. North K, Joy P, Yuille D, Cocks N, Mobbs E, Hutchins P, McHugh K, de Silva M (1994) Specific learning disability in children with neurofibromatosis type 1: significance of MRI abnormalities. Neurology 44:878-883 (Pubitemid 24158804)
15. Denckla MB, Hofman K, Mazzocco MM, Melhem E, Reiss AL, Bryan RN, Harris EL, Lee J, Cox CS, Schuerholz LJ (1996) Relationship between T2-weighted hyperintensities (unidentified bright objects) and lower IQs in children with neurofibromatosis-1. Am J Med Genet 67:98-102
16. Goh WH, Khong PL, Leung CS, Wong VC (2004) T2-weighted hyperintensities (unidentified bright objects) in children with neurofibromatosis 1: their impact on cognitive function. J Child Neurol 19:853-858 (Pubitemid 40090102)
17. Castillo M, Green C, Kwock L, Smith K, Wilson D, Schiro S, Greenwood R (1995) Proton MR spectroscopy in patients with neurofibromatosis type 1: evaluation of hamartomas and clinical correlation. AJNR Am J Neuroradiol 16:141-147
18. Itoh T, Magnaldi S, White RM, Denckla MB, Hofman K, Naidu S, Bryan RN (1994) Neurofibromatosis type 1: the evolution of deep gray and white matter MR abnormalities. AJNR Am J Neuroradiol 15:1513-1519 (Pubitemid 24285906)
19. Gonen O, Wang ZJ, Viswanathan AK, Molloy PT, Zimmerman RA (1999) Three-dimensional multivoxel proton MR spectroscopy of the brain in children with neurofibromatosis type 1. AJNR Am J Neuroradiol 20:1333-1341 (Pubitemid 29400549)
20. Sevick RJ, Barkovich AJ, Edwards MS, Koch T, Berg B, Lempert T (1992) Evolution of white matter lesions in neurofibromatosis type 1: MR findings. AJR Am J Roentgenol 159:171-175
21. Kim G, Mehta M, Kucharczyk W, Blaser S (1998) Spontaneous regression of a tectal mass in neurofibromatosis 1. AJNR Am J Neuroradiol 19:1137-1139 (Pubitemid 30408101)
22. Wilkinson ID, Griffiths PD, Wales JK (2001) Proton magnetic resonance spectroscopy of brain lesions in children with neurofibromatosis type 1. Mag Reson Imaging 19:1081-1089
23. Hyman SL, Gill DS, Shores EA, Steinberg A, North KN (2007) T2 hyperintensities in children with neurofibromatosis type 1 and their relationship to cognitive functioning. J Neurol Neurosurg Psychiatry 78:1088-1091
24. Wang PY, Kaufmann WE, Koth CW, Denckla MB, Barker PB (2000) Thalamic involvement in neurofibromatosis type 1: evaluation with proton magnetic resonance spectroscopic imaging. Ann Neurol 47:477-484 (Pubitemid 30194604)
25. Jones AP, Gunawardena WJ, Coutinho CM (2001) 1H MR spectroscopy evidence for the varied nature of asymptomatic focal brain lesions in neurofibromatosis type 1. Neuroradiology 43:62-67 (Pubitemid 32123970)
26. National Institutes of Health Consensus Development Conference (1988) Neurofibromatosis: conference statement. Arch Neurol 45:575-578
27. Schrimsher GW, Billingsley RL, Slopis JM, Moore BD (2003) Visual-spatial performance deficits in children with neurofibromatosis type-1. Am J Med Genet 120A:326-330 (Pubitemid 37063766)
28. Sastre-Garriga J, Ingle GT, Chard DT, Ramió-Torrentà L, McLean MA, Miller DH, Thompson AJ (2005) Metabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis. Arch Neurol 62:569-573 (Pubitemid 40489887)
29. Alkan A, Sarac K, Kutlu R, Yakinci C, Sigirci A, Aslan M, Ozcan H, Yologlu S (2003) Proton MR spectroscopy features of normal appearing white matter in neurofibromatosis type 1. Mag Reson Imaging 21:1049-1053 (Pubitemid 37549869)
30. Cui Y, Costa RM, Murphy GG, Elgersma Y, Zhu Y, Gutmann DH, Parada LF, Mody I, Silva AJ (2008) Neurofibromin regulation of ERK signaling modulates GABA release and learning. Cell 135:549-560
31. Chatham JC, Blackband SJ (2001) Nuclear magnetic resonance spectroscopy and imaging in animal research. ILAR J 42:189-208 (Pubitemid 33708708)
32. Zhu Y, Harada T, Liu L, Lush ME, Guignard F, Harada C, Burns DK, Bajenaru ML, Gutmann DH, Parada LF (2005) Inactivation of NF1 in CNS causes increased glial progenitor proliferation and optic glioma formation. Development 132:5577-5588 (Pubitemid 43125883)
33. Brown JA, Emnett RJ, White CR, Yuede C, Conyers S, O'Malley KL, Wozniak DF, Gutmann DH (2010) Reduced striatal dopamine underlies the attention system dysfunction in neurofibromatosis-1 mutant mice. Hum Mol Genet 7. doi:10.1093/hmg/ddq382
34. Gill DS, Hyman SL, Steinberg A, North KN (2006) Age-related findings on MRI in neurofibromatosis type 1. Pediatr Radiol 36:1048-1056 (Pubitemid 44377857)
35. Van der Werf YD, Witter MP, Uylings HB, Jolles J (2000) Neuropsychology of infarctions in the thalamus: a review. Neuropsychologia 38:613-627 (Pubitemid 30109441)